All Reports Events Blogs Videos
Showing 148 results
  • NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • Blog
    July 29, 2026

    The pharmaceutical technology market is moving beyond point solutions. For years, providers competed by solving specific problems within individual parts of the value chain. Today, differentiation increasingly depends on how well those solutions can understand context,…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Blog
    July 14, 2026

    Life Sciences commercial teams have a familiar problem: every few years, the industry finds a new way to create fragmentation.  First came Customer Relationship Management (CRM) add-ons. Then omnichannel tools, content platforms, analytics dashboards, field enablement systems, event platforms,…
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • Blog
    June 09, 2026

    For years, life sciences commercial technology providers sold nouns. Customer Relationship Management (CRM). Analytics. Content. Events. Patient engagement. Next-best-action. Learning. Field enablement.  Each category had its own buyer, its own implementation partner, its own operating model, and often its own dashboard.…
  • Viewpoint
    March 31, 2026

    To keep pace with macroeconomic uncertainties, supply chain volatility, and growing business expectations, procurement leaders must deliver more than operational efficiency. The modern mandate calls for agility, intelligence, and measurable value. However, fragmented systems, siloed workflows,…
  • Viewpoint
    March 25, 2026

    Procurement has historically focused on cost savings and operational efficiency, supported by spend visibility and reporting tools. However, AI advances are fundamentally reshaping this model by enabling continuous, intelligence-driven procurement decision-making. Agentic AI introduces autonomy into…
  • Blog
    March 24, 2026

    The procurement technology landscape is expanding at a pace that reflects more than incremental digitization. Across sourcing, contracting, spend intelligence, vendor management, and accounts payable solutions, providers are proliferating, capital is flowing, and enterprises are broadening their digital roadmaps.  This proliferation has resulted in a diverse technology landscape marked by:  Traditional integrated suites anchoring…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Blog
    March 17, 2026

    For years, procurement was defined by one outcome: savings achieved through negotiations, competitive bidding, and benchmarking. Later, technology -driven efficiency became an additional priority. With this, the performance improved, but the perception did not. Procurement remained operational, important, yet rarely strategic.  Now, the shift is unmistakable. Agentic Artificial Intelligence (AI) is changing…
  • Viewpoint
    March 03, 2026

    Procurement is at a pivotal inflection point. After a decade of digital transformation focused on automation, compliance, and analytics, many organizations have reached a plateau where process automation remains rule-based and heavily dependent on human intervention…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Feb. 04, 2026

    As the Veeva ecosystem continues to expand rapidly - now representing a market of nearly $2 billion- life sciences organizations are rethinking how they approach Veeva-enabled transformation. What was once focused primarily on implementation is evolving…
  • Video
    Feb. 03, 2026

    As Veeva becomes the cornerstone of strategic transformation in life sciences, expectations from service providers are rapidly evolving. In this Q&A session, Chunky Satija, Vice President, and Rohit K, Practice Director, from Everest Group, discuss the…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • Market Insights™
    Jan. 02, 2026

Items per page